GlobeNewswire
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
📈
AI Sentiment
Highly Positive
8/10
OKYO Pharma Limited News
Latest updates and market news for OKYO
1 news
Jan 20 - Jan 26, 2026
Page 1
Share this news page